Drug Price Trends for WESTUSSIN DM

Average Pharmacy Cost for WESTUSSIN DM

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
WESTUSSIN DM NF 2-15-7.5 MG/5 ML	69367-0353-16	0.04837	ML	2024-09-18
WESTUSSIN DM 1-5-10 MG/5 ML SYR	69367-0334-16	0.04102	ML	2024-09-18
WESTUSSIN DM 1-5-10 MG/5 ML SYR	69367-0334-16	0.04476	ML	2024-08-21
WESTUSSIN DM 1-5-10 MG/5 ML SYR	69367-0334-16	0.04566	ML	2024-07-17
WESTUSSIN DM 1-5-10 MG/5 ML SYR	69367-0334-16	0.04588	ML	2024-06-19
WESTUSSIN DM NF 2-15-7.5 MG/5 ML	69367-0353-16	0.04708	ML	2024-06-19

Market Analysis and Price Projections for WESTUSSIN DM

Overview of WESTUSSIN DM

WESTUSSIN DM is a over-the-counter (OTC) medication that combines dexchlorpheniramine maleate, dextromethorphan HBr, and phenylephrine HCl. It is designed to temporarily relieve cough due to minor throat and bronchial irritation, nasal congestion, and other symptoms associated with colds and allergies[1].

Market Trends for Cough and Cold Medications

The market for cough and cold medications, including those containing dextromethorphan, is influenced by several key factors:

Seasonal Demand

The demand for cough and cold medications is highly seasonal, with peak sales typically occurring during the flu and cold seasons. This seasonal fluctuation can impact the overall market size and pricing strategies[3].

Product Launches and Approvals

New product launches and approvals can significantly boost market growth. For example, the FDA approval of Auvelity (dextromethorphan HBr-bupropion HCl) for the treatment of major depressive disorder has expanded the therapeutic uses of dextromethorphan, potentially increasing its market demand[3].

Geographic Market

North America is the largest market for dextromethorphan-based medications, driven by factors such as rising cases of flu, an increasing geriatric population, and a trend towards self-medication. The Asia Pacific region is expected to be the fastest-growing market due to similar factors[3].

Price Projections

Overall Pharmaceutical Market Inflation

According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected to be 3.81% for 2025. This inflation rate is influenced by various factors, including the expanding indications of previously approved medications and the introduction of high-cost therapies[2].

Specific to Dextromethorphan Market

The dextromethorphan market itself is expected to grow at a compound annual growth rate (CAGR) of 4.1% over the forecast period from 2024 to 2029. This growth is driven by increasing cases of flu and cold, as well as new product launches and approvals[3].

Factors Influencing Pricing

Raw Material Costs and Manufacturing

Changes in the costs of raw materials and manufacturing processes can impact the pricing of WESTUSSIN DM. However, these costs are generally stable for well-established medications like dextromethorphan.

Regulatory Environment

Regulatory changes, such as restrictions on the sale of dextromethorphan to minors in some states, can affect pricing by influencing demand and supply dynamics. However, these regulations are more about access control rather than direct price impact[4].

Competitive Landscape

The competitive landscape of the cough and cold medication market is diverse, with many generic and brand-name products available. This competition can keep prices relatively stable, as manufacturers aim to remain competitive in the market[4].

Price Inflation and Budget Impact

Healthcare Provider Budgets

Healthcare providers and pharmacies need to prepare for potential price increases, especially with the introduction of new and expensive therapies. However, for OTC medications like WESTUSSIN DM, the impact is generally less severe compared to prescription drugs. The projected 3.81% inflation rate for pharmaceuticals will likely have a moderate effect on the pricing of WESTUSSIN DM[2].

Consumer Impact

For consumers, the price increase will be relatively minor, given the overall low cost of OTC medications. However, frequent users or those with chronic conditions may feel the impact more significantly.

Market Growth Drivers

Increasing Incidence of Flu and Cold

The increasing incidence of flu and cold cases globally is a significant driver for the demand of dextromethorphan-based medications. For instance, the flu affects around 8.0% of the U.S. population annually, contributing to the sustained demand for these medications[3].

New Indications and Product Launches

The approval of new indications for existing medications, such as the use of dextromethorphan in treating major depressive disorder, expands the market potential and can drive growth[3].

Challenges and Restraints

Side Effects and Abuse Potential

Dextromethorphan is known for its potential for abuse and side effects, which can restrain market growth. Regulatory bodies have considered stricter controls, but so far, these have been limited to age restrictions in some states[4].

Key Takeaways

• Market Growth: The dextromethorphan market is expected to grow at a CAGR of 4.1% from 2024 to 2029.
• Price Inflation: The overall pharmaceutical market is projected to see a 3.81% inflation rate in 2025.
• Demand Drivers: Increasing cases of flu and cold, new product launches, and expanded therapeutic uses are key drivers.
• Challenges: Side effects and abuse potential are significant restraints.

FAQs

Q: What are the main ingredients in WESTUSSIN DM? A: WESTUSSIN DM contains dexchlorpheniramine maleate, dextromethorphan HBr, and phenylephrine HCl[1].

Q: What is the projected growth rate for the dextromethorphan market? A: The dextromethorphan market is expected to grow at a CAGR of 4.1% from 2024 to 2029[3].

Q: How does the seasonal demand impact the market for cough and cold medications? A: Seasonal demand significantly impacts the market, with peak sales during flu and cold seasons[3].

Q: What are some of the new therapeutic uses of dextromethorphan? A: Dextromethorphan has been approved for use in treating major depressive disorder, in addition to its traditional use as a cough suppressant[3].

Q: Are there any regulatory restrictions on the sale of dextromethorphan? A: Yes, some states have restricted the sale of dextromethorphan to minors, and there have been considerations for stricter controls due to its potential for abuse[4].

Sources

1. DailyMed: WESTUSSIN DM- dexchlorpheniramine maleate, dextromethorphan hbr, phenylephrine hcl syrup.
2. Vizient Inc.: Vizient projects drug price inflation at 3.81%.
3. Mordor Intelligence: Dextromethorphan Market Size & Share Analysis - Growth Trends.
4. Wikipedia: Dextromethorphan.